Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Avinger Inc is a medical instruments & supplies business based in the US. Avinger shares (AVGR) are listed on the NASDAQ and all prices are listed in US Dollars. Avinger employs 68 staff and has a trailing 12-month revenue of around $8.8 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $1.22 |
|---|---|
| 52-week range | $1.13 - $19.26 |
| 50-day moving average | $1.51 |
| 200-day moving average | $3.79 |
| Wall St. target price | $6.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-5.60 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.22 from 2022-09-29
| 1 week (2022-09-23) | 5.17% |
|---|---|
| 1 month (2022-09-01) | -14.08% |
| 3 months (2022-07-01) | -17.57% |
| 6 months (2022-04-01) | -65.44% |
| 1 year (2021-10-01) | 67.10% |
|---|---|
| 2 years (2020-10-01) | 276.31% |
| 3 years (2019-10-01) | 46.88% |
| 5 years (2017-09-29) | 220.72% |
| Revenue TTM | $8.8 million |
|---|---|
| Gross profit TTM | $3.4 million |
| Return on assets TTM | -33.47% |
| Return on equity TTM | -170.44% |
| Profit margin | -219.16% |
| Book value | $0.88 |
| Market capitalisation | $8.1 million |
TTM: trailing 12 months
We're not expecting Avinger to pay a dividend over the next 12 months.
Avinger's shares were split on a 1:20 basis on 14 March 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avinger shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Avinger shares which in turn could have impacted Avinger's share price.
Over the last 12 months, Avinger's shares have ranged in value from as little as $1.132 up to $19.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avinger's is 1.6121. This would suggest that Avinger's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avinger, Inc. , a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.